EMA provisionally approves first antibody-drug conjugate for multiple myeloma

European Medicines Agency human medicines committee recommends granting conditional licence to belantamab mafodotin.
European Medicines Agency human medicines committee recommends granting conditional licence to belantamab mafodotin.